Skip to content

CALISTHERAPY

Active
Private limited companyfounded 20242 yrs activeVennenstraat 26, 3920 Lommel, BelgiumKBO/BCE: BE 1006.166.548
Summary

The computed 12-month bankruptcy probability of CALISTHERAPY is 2.5% (moderate). The 2025 annual accounts show equity of €69,069 and a net result of €37,715. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes · tick = 2024
Profitability100=
Solvency84▲+1
Growth78
Track record82
Bankruptcy probability, 12 months
2.5% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €5,000 at 30 days acceptable
Liquidity ample (current ratio 3.06 against 1.65 in 2024; short-term debt: 19.7% and cash: 60.3% of total assets), and 41.1% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
58.9%
Return on assets
32.2%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
31 d early
2024
32 d early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 2 accounts on average 32 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

CALISTHERAPY was incorporated on 19 February 2024 as a Private limited company.1 The company has filed 2 sets of annual accounts, the latest for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€69,069▲ 120%
2024 · €31,354
Total assets
€117,282▲ 116%
2024 · €54,344
Net result
€37,715▲ 43.1%
2024 · €26,354
Working capital
€47,607▲ 218%
2024 · €14,980
Trend over the years
In euros
In euros
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20242025
Operating result€33,844-€51,889▲ 53.3%
Net result€26,354-€37,715▲ 43.1%
Equity€31,354-€69,069▲ 120%
Total assets€54,344-€117,282▲ 116%
Debt€22,991-€48,213▲ 110%
Working capital€14,980-€47,607▲ 218%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20,000€40,000€60,000Operating result 2024: €33,844€33,844Net result 2024: €26,354€26,354Operating result 2025: €51,889€51,889Net result 2025: €37,715€37,71520242025€0€20,000€40,000€60,000Operating result 2024: €33,844€33,800Net result 2024: €26,354€26,400Operating result 2025: €51,889€51,900Net result 2025: €37,715€37,70020242025
The operating result rises in 2025; 2025 is 53% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €117,282
Fixed assets €46,524 ▲ 184%
Current assets €70,758 ▲ 86.3%
Equity and liabilities €117,282
Equity €69,069 ▲ 120%
Debt €48,213 ▲ 110%
Debt's share of the balance-sheet total falls from 42.3% to 41.1%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€57,535▲
2024 · €37,058
Cash flow
€43,361▲
2024 · €29,568
Current ratio
3.06▲
2024 · 1.65
Debt to equity
0.70▼
2024 · 0.73
ROE
54.6%▼
2024 · 84.1%
ROA
32.2%▼
2024 · 48.5%
Interest coverage
85.33▼
2024 · 1530.70
Debt ≤ 1 year
€23,150▲
2024 · €22,991
Debt > 1 year
€25,063
Income taxes
€13,793▲
2024 · €7,496
Staff costs
€1,920▲
2024 · €1,600
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 96% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
96% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a higher bankruptcy probability: 2.5% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 39 lines
Balance sheet Code20242025
Assets
Total assets20/58€54,344€117,282▲
Fixed assets21/28€16,374€46,524▲
Tangible fixed assets22/27€16,374€46,524▲
Land and buildings22-€1,932
Plant, machinery and equipment23€1,315€997▼
Furniture and vehicles24€15,059€43,595▲
Current assets29/58€37,971€70,758▲
Cash at bank and in hand54/58€37,971€70,758▲
Equity and liabilities
Total equity and liabilities10/49€54,344€117,282▲
Equity10/15€31,354€69,069▲
Contributions10/11€5,000€5,000=
Profit (loss) carried forward14€26,354€64,069▲
Amounts payable17/49€22,991€48,213▲
Amounts payable after more than one year17-€25,063
Financial debts170/4-€25,063
Amounts payable within one year42/48€22,991€23,150▲
Current portion of amounts payable after more than one year42-€6,676
Trade debts44€13,703€8,854▼
Suppliers440/4€13,703€8,854▼
Taxes, remuneration and social security45€9,287€4,505▼
Taxes450/3€7,487€2,705▼
Remuneration and social security454/9€1,800€1,800=
Other amounts payable47/48-€3,115
Income statement Code20242025
Remuneration, social security and pensions62€1,600€1,920▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,214€5,646▲
Other operating charges640/8€106€1,053▲
Non-recurring operating charges66A-€59
Gross operating margin9900€38,764€60,567▲
Operating profit (loss)9901€33,844€51,889▲
Financial income75/76B€30€293▲
Recurring financial income75€30€293▲
Financial charges65/66B€24€674▲
Recurring financial charges65€24€674▲
Profit (loss) for the period before taxes9903€33,850€51,508▲
Income taxes67/77€7,496€13,793▲
Profit (loss) for the period9904€26,354€37,715▲
Profit (loss) for the period to be appropriated9905€26,354€37,715▲
Appropriation of the result
Profit (loss) to be appropriated9906€26,354€64,069▲
Profit (loss) brought forward from the previous period14P-€26,354

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20242025Change
Remuneration, social security and pensions62€1,600€1,920▲ 20.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,214€5,646▲ 75.6%
Other operating charges640/8€106€1,053▲ 898%
Non-recurring operating charges66A-€59-
Gross operating margin9900€38,764€60,567▲ 56.2%
Operating profit (loss)9901€33,844€51,889▲ 53.3%
Financial income75/76B€30€293▲ 877%
Recurring financial income75€30€293▲ 877%
Financial charges65/66B€24€674▲ 2,685%
Recurring financial charges65€24€674▲ 2,685%
Profit (loss) for the period before taxes9903€33,850€51,508▲ 52.2%
Income taxes67/77€7,496€13,793▲ 84.0%
Profit (loss) for the period9904€26,354€37,715▲ 43.1%
Profit (loss) for the period to be appropriated9905€26,354€37,715▲ 43.1%
Line20242025Change
Assets
Total assets20/58€54,344€117,282▲ 116%
Fixed assets21/28€16,374€46,524▲ 184%
Tangible fixed assets22/27€16,374€46,524▲ 184%
Land and buildings22-€1,932-
Plant, machinery and equipment23€1,315€997▼ 24.2%
Furniture and vehicles24€15,059€43,595▲ 189%
Current assets29/58€37,971€70,758▲ 86.3%
Cash at bank and in hand54/58€37,971€70,758▲ 86.3%
Equity and liabilities
Total equity and liabilities10/49€54,344€117,282▲ 116%
Equity10/15€31,354€69,069▲ 120%
Contributions10/11€5,000€5,000=
Profit (loss) carried forward14€26,354€64,069▲ 143%
Amounts payable17/49€22,991€48,213▲ 110%
Amounts payable after more than one year17-€25,063-
Financial debts170/4-€25,063-
Amounts payable within one year42/48€22,991€23,150▲ 0.7%
Current portion of amounts payable after more than one year42-€6,676-
Trade debts44€13,703€8,854▼ 35.4%
Suppliers440/4€13,703€8,854▼ 35.4%
Taxes, remuneration and social security45€9,287€4,505▼ 51.5%
Taxes450/3€7,487€2,705▼ 63.9%
Remuneration and social security454/9€1,800€1,800=
Other amounts payable47/48-€3,115-
Line20242025Change
Profit (loss) for the period9904€26,354€37,715▲ 43.1%
+ Depreciation and write-downs630€3,214€5,646▲ 75.6%
Operating cash flow (approximation)€29,568€43,361▲ 46.6%
Investment in fixed assets (approximation)--€35,796-
Change in cash-€32,787-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
29-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
NBB filing
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
No directors read yet: 0 of 2 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Lommel · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
720 m²
Building footprint
139 m²
Volume, LiDAR
720 m³
Parcel 72345B2030/00A000, Flanders · tallest building 7.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
CALISTHERAPY
Vennenstraat 26, 3920 LommelHuman health activities
since 20242.355.965.890
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
72345B2030/00A000 Flanders 720 m² 1 · 139 m² 7.1 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Subsidies and aid

Flemish government

2025 · 1 entry · 113 EUR awarded · 113 EUR paid
Year Entries awardedpaid
2025 1 113 EUR113 EUR
Schemes
1 entry · 113 EUR · 113 EUR paid · Fonds voor Innoveren en Ondernemen

Company details

Identification
Legal formPrivate limited company
Founded19-02-2024
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:1006166548
Also 9925:BE1006166548
Registered 18-11-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.